Eighth Edition - R.3 - Human Fertilisation & Embryology Authority

Index
preimplantation tissue typing indication 10E, 10.21, 10.22
risk of, in PGD indications/decision-making 10.4, 10.5, 10.6
unsuspected in donors, notification 11.21–11.23
HFE (Special Exemptions) Regulations 2009 22A, 22C
HFEA Directions
adverse incidents
27A
import/export see imports and exports
(of gametes/embryos)
HFEA Register, information on donors 11.24h, 30.15
egg donors 12.24c
histocompatibility (tissue typing), PGD
for see preimplantation tissue typing
HIV1 and HIV2
donors must be negative for
T52b(11)
screening before storage of gametes/embryos T50(17)
home insemination 15B, 15.4–15.5
home procurement, sperm T68(15), 15.6–15.9
HTLV1, donor screening for
T52g(11)
before storage of gametes/embryos
T50(17)
human admixed embryos
consent for creating
5A, 5D, 22G
consent for storage
5D, 22G
counselling requirement before
3A
development time restrictions
R28(22)
information provision before consent
4A, 22F
information recorded before 22.3
labelling
R26(22)
legal prohibitions affecting
22A, 22E
maximum storage time
R37(22)
money/benefit receipt, as criminal offence
13A
no money for
R24(22)
research use without consent, circumstances 22D
storage, conditions for
R34(22), 22G
supply to person to whom another licence applies R25(22)
use for purposes of research project only R23(22)
human cells, use
22D
human embryonic stem cell lines see stem cell lines
Human Rights Act, 1998 29A, 29.1
Human Tissue Authority 17.10
hygiene, equipment/materials for staff 26.2
I
ICSI see intra-cytoplasmic sperm injection (ICSI)
ICSI practitioners 2.20–2.21
identifiers (identifying codes)
for donors 18.5, 19.2a
for gametes/embryos 18.5, 18.20, 18.21, 19.2b
information on materials/equipment
to be documented
T22(26)
identity verification 19.1a
for consent provision 5.10, 5.11
for legal parenthood 6.9
varying/withdrawing of consent 5.34, 6.9
of donors 11.6, 18.17
of egg providers 12.15
of gametes and embryos 19.1a
home sperm procurement 15.7a, 15.7b
identifying codes see identifiers (identifying codes)
of patients and/or partners 5.11, 19.1a
requests under Data Protection Act 30.9
self-referrals 8.8, 18.17
for treatment 5.11
for welfare of child risk assessment in self-referrals 8.8
see also traceability
implications of treatment, counselling on T60(3), 3.3, 5B,
5.9b, 20.9
imports and exports (of gametes/embryos) 16.1–16.6
consent requirements
5A
decision tree 16.2
donors, previous donation/use of gametes 11.7
General Directions
evidence of compliance
(within/outside EEA and Gibraltar)
16B
notification of HFEA about transfers
16C
information for patients/donors 16.1
patient/donor registration
16A
responsibilities of person responsible 16A, 16B, 16C
Special Directions
within EEA and Gibraltar 16.4–16.5
not available for unaccredited centres 16.5
notification of HFEA
16C
outside EEA and Gibraltar 16.6
traceability of gametes 19.4
traceability of materials/equipment 16B, 16.3
incidents see adverse incidents
induction programme, scientists/scientific staff 2.17
infection risk, donor eggs, information on risk 4.2h
infertility counselling,
specialist competence of counsellors 2.12
information
to be provided to Authority in support of inspection T4(32)
held by centres
30A
management, documented procedures 31.8
not to be removed from records
before expiry period
T40(31)
recorded as specified in Directions
T39(31)
Information Commissioner 30.5d
information provision (by centre) 4A, 4.1–4.4
on centre’s duty on welfare of child assessment 4.2b
for children/young people 5.32
on complaints procedure 4.2k, 28.5
on conscientious objection by staff 29.14b
for consent (obtaining consent) see consent
on costs of treatment 4.3
on counselling, for patients 3.2
counselling offer distinguished from 3.7b, 4.1
for disclosure of identifying information 5.26
in agreement between centre
and recipient 12.24, 12.25, 12.26
about donors see donors
Human Fertilisation and Embryology Authority
Index
Version 3.0